These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 22008704

  • 1. Functional importance of apolipoprotein A5 185G in the activation of lipoprotein lipase.
    Huang YJ, Lin YL, Chiang CI, Yen CT, Lin SW, Kao JT.
    Clin Chim Acta; 2012 Jan 18; 413(1-2):246-50. PubMed ID: 22008704
    [Abstract] [Full Text] [Related]

  • 2. Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding.
    Dorfmeister B, Zeng WW, Dichlberger A, Nilsson SK, Schaap FG, Hubacek JA, Merkel M, Cooper JA, Lookene A, Putt W, Whittall R, Lee PJ, Lins L, Delsaux N, Nierman M, Kuivenhoven JA, Kastelein JJ, Vrablik M, Olivecrona G, Schneider WJ, Heeren J, Humphries SE, Talmud PJ.
    Arterioscler Thromb Vasc Biol; 2008 Oct 18; 28(10):1866-71. PubMed ID: 18635818
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
    Martín-Campos JM, Julve J, Roig R, Martínez S, Errico TL, Martínez-Couselo S, Escolà-Gil JC, Méndez-González J, Blanco-Vaca F.
    Clin Chim Acta; 2014 Feb 15; 429():61-8. PubMed ID: 24291057
    [Abstract] [Full Text] [Related]

  • 5. Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis.
    Xie SL, Chen TZ, Huang XL, Chen C, Jin R, Huang ZM, Zhou MT.
    PLoS One; 2015 Feb 15; 10(6):e0129488. PubMed ID: 26079787
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity.
    Chen YQ, Yang Y, Zhen EY, Beyer TP, Li H, Wen Y, Ehsani M, Jackson N, Xie K, Jung H, Scheithauer JL, Kumari A, Birrane G, Russell AM, Balasubramaniam D, Liao Z, Siegel RW, Qian Y, Ploug M, Young SG, Konrad RJ.
    Proc Natl Acad Sci U S A; 2024 Apr 23; 121(17):e2322332121. PubMed ID: 38625948
    [Abstract] [Full Text] [Related]

  • 10. The pathogenic mutations of APOA5 in Chinese patients with hyperlipidemic acute pancreatitis.
    Liu Y, Dai S, Qin S, Zhou J, Wang Z, Yin G.
    Lipids Health Dis; 2024 Feb 08; 23(1):44. PubMed ID: 38331899
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia.
    Chokshi N, Blumenschein SD, Ahmad Z, Garg A.
    J Clin Lipidol; 2014 Feb 08; 8(3):287-95. PubMed ID: 24793350
    [Abstract] [Full Text] [Related]

  • 13. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.
    Di Filippo M, Marçais C, Charrière S, Marmontel O, Broyer M, Delay M, Merlin M, Nollace A, Valéro R, Lagarde M, Pruneta-Deloche V, Moulin P, Sassolas A.
    PLoS One; 2014 Feb 08; 9(6):e99721. PubMed ID: 24886863
    [Abstract] [Full Text] [Related]

  • 14. Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumen.
    Yang Y, Beigneux AP, Song W, Nguyen LP, Jung H, Tu Y, Weston TA, Tran CM, Xie K, Yu RG, Tran AP, Miyashita K, Nakajima K, Murakami M, Chen YQ, Zhen EY, Kim JR, Kim PH, Birrane G, Tontonoz P, Ploug M, Konrad RJ, Fong LG, Young SG.
    J Clin Invest; 2023 Dec 01; 133(23):. PubMed ID: 37824203
    [Abstract] [Full Text] [Related]

  • 15. APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillaries.
    Yang Y, Konrad RJ, Ploug M, Young SG.
    J Lipid Res; 2024 Jul 01; 65(7):100578. PubMed ID: 38880127
    [Abstract] [Full Text] [Related]

  • 16. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
    Kim JY, Kim OY, Paik JK, Lee SH, Lee JH.
    J Clin Lipidol; 2013 Jul 01; 7(2):94-101. PubMed ID: 23415427
    [Abstract] [Full Text] [Related]

  • 17. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.
    Surendran RP, Visser ME, Heemelaar S, Wang J, Peter J, Defesche JC, Kuivenhoven JA, Hosseini M, Péterfy M, Kastelein JJ, Johansen CT, Hegele RA, Stroes ES, Dallinga-Thie GM.
    J Intern Med; 2012 Aug 01; 272(2):185-96. PubMed ID: 22239554
    [Abstract] [Full Text] [Related]

  • 18. Apolipoprotein A5: Extracellular and Intracellular Roles in Triglyceride Metabolism.
    Forte TM, Ryan RO.
    Curr Drug Targets; 2015 Aug 01; 16(12):1274-80. PubMed ID: 26028042
    [Abstract] [Full Text] [Related]

  • 19. Identification of a lipoprotein lipase cofactor-binding site by chemical cross-linking and transfer of apolipoprotein C-II-responsive lipolysis from lipoprotein lipase to hepatic lipase.
    McIlhargey TL, Yang Y, Wong H, Hill JS.
    J Biol Chem; 2003 Jun 20; 278(25):23027-35. PubMed ID: 12682050
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.